IMMX
IMMX
NASDAQ · Biotechnology

Immix Biopharma Inc

$9.11
-0.57 (-5.89%)
As of Mar 22, 10:26 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +31.5% upside
Low Target $7.05
Average Target $11.98
High Target $14.20
Current Price $9.11
Current
$9.11
Target
$11.98
$7.05 $11.98 avg $14.20
Scenario Analysis
Bear Case
$7.05
-22.6%
Low target
Base Case
$11.98
+31.5%
Avg target
Bull Case
$14.20
+55.9%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$8.97
1.6% from high
52-Week Low
$1.34
+579.9% from low
Target vs 52W High
$11.98
+33.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%